Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Anne Stidsholt Roug, Hans Beier Ommen

ABSTRACT

OPINION STATEMENT: Treatment of acute myeloid leukemia (AML) remains a high-risk venture for the patient suffering from the disease. There is a real risk of succumbing to the treatment rather than the disease, and even so, cure is much less than certain. Since the establishment of complete remission as a prerequisite for cure in the 1960s, a number of years passed before advanced techniques for detecting minute amounts of disease matured sufficiently for clinical implementation. The two main techniques for detection of measurable residual disease (MRD) remain qPCR and multicolor flow cytometry. When performed in expert laboratories, both these modalities offer treating physicians excellent opportunity to follow the amount of residual disease upon treatment and offer unparalleled prognostication. In some AML and age group subsets, evidence now exist to support the choice of both proceeding to allogeneic transplant and not doing so. In other AML subgroups, MRD has sufficient discriminative power to identify patients likely to benefit from allogeneic transplant and patients likely not to. After treatment or transplantation, follow-up by molecular techniques can, with high certainty, predict relapse months before bone marrow function deterioration. On the other hand, options upon so-called molecular relapse are less well tested but recent evidence supports the use of azacitidine both in transplanted patients and patients consolidated with chemotherapy. In conclusion, MRD testing during treatment is a superb prognosticator and a major tool when choosing whether a patient should be transplanted or not. The exact use of MRD testing after treatment is less well defined but evidence is mounting for the instigation of treatment upon rising MRD levels (pre-emptive treatment) before morphologically detectable relapse. More... »

PAGES

28

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11864-019-0627-4

DOI

http://dx.doi.org/10.1007/s11864-019-0627-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112761617

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30874904


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Aalborg University", 
          "id": "https://www.grid.ac/institutes/grid.5117.2", 
          "name": [
            "Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, M\u00f8lleparkvej 4, DK-9000, Aalborg, Denmark", 
            "Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roug", 
        "givenName": "Anne Stidsholt", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aarhus University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.154185.c", 
          "name": [
            "Department of Hematology, Aarhus University Hospital, Palle-Juul Jensens Boulevard 99, DK-8200, Aarhus N, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ommen", 
        "givenName": "Hans Beier", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1507471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001798183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.58.3518", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002897148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2014.90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004209539", 
          "https://doi.org/10.1038/leu.2014.90"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2014.90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004209539", 
          "https://doi.org/10.1038/leu.2014.90"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-03-213389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008844336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-11-468348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010315401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-04-212530", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010662814"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.49.1753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011453119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjh.12792", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011762816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra1406184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011899386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.1496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016977002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.45.9628", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017813803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029511634", 
          "https://doi.org/10.1038/sj.leu.2404313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029511634", 
          "https://doi.org/10.1038/sj.leu.2404313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-015-2364-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031095879", 
          "https://doi.org/10.1007/s00277-015-2364-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2009.07770.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032893066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2009.07770.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032893066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.67.1875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035196420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2008.07132.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038105173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.35.0371", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038855887"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.318", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039759999", 
          "https://doi.org/10.1038/leu.2013.318"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2009.007765", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040541320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.58.0571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040750785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-05-577593", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050367002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2013-01-480590", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052849109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2016-08-733196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064123306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074581593", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082552338", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/17474086.2017.1326811", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085346701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2017.0116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090396386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2017.0116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090396386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-09-801498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100381779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-09-801498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100381779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-09-801498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100381779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-09-801498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100381779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-09-801498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100381779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2017.76.3425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101852368"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/bloodadvances.2018016378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104568608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/bloodadvances.2018016378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104568608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/cancers10070215", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105127918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(18)30580-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109824401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(18)30580-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109824401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0366-6999.246072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110162477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0366-6999.246072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110162477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0366-6999.246072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110162477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41375-018-0326-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110559543", 
          "https://doi.org/10.1038/s41375-018-0326-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41375-018-0326-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110559543", 
          "https://doi.org/10.1038/s41375-018-0326-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41375-018-0326-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110559543", 
          "https://doi.org/10.1038/s41375-018-0326-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0000000000000482", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111027519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0000000000000482", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111027519"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "OPINION STATEMENT: Treatment of acute myeloid leukemia (AML) remains a high-risk venture for the patient suffering from the disease. There is a real risk of succumbing to the treatment rather than the disease, and even so, cure is much less than certain. Since the establishment of complete remission as a prerequisite for cure in the 1960s, a number of years passed before advanced techniques for detecting minute amounts of disease matured sufficiently for clinical implementation. The two main techniques for detection of measurable residual disease (MRD) remain qPCR and multicolor flow cytometry. When performed in expert laboratories, both these modalities offer treating physicians excellent opportunity to follow the amount of residual disease upon treatment and offer unparalleled prognostication. In some AML and age group subsets, evidence now exist to support the choice of both proceeding to allogeneic transplant and not doing so. In other AML subgroups, MRD has sufficient discriminative power to identify patients likely to benefit from allogeneic transplant and patients likely not to. After treatment or transplantation, follow-up by molecular techniques can, with high certainty, predict relapse months before bone marrow function deterioration. On the other hand, options upon so-called molecular relapse are less well tested but recent evidence supports the use of azacitidine both in transplanted patients and patients consolidated with chemotherapy. In conclusion, MRD testing during treatment is a superb prognosticator and a major tool when choosing whether a patient should be transplanted or not. The exact use of MRD testing after treatment is less well defined but evidence is mounting for the instigation of treatment upon rising MRD levels (pre-emptive treatment) before morphologically detectable relapse.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11864-019-0627-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1022080", 
        "issn": [
          "1527-2729", 
          "1534-6277"
        ], 
        "name": "Current Treatment Options in Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "name": "Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia", 
    "pagination": "28", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4ec7c380fc81716e136a5338d69a157bc38c92e0e90a88743a0e9af5b6fea2f4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30874904"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100900946"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11864-019-0627-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112761617"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11864-019-0627-4", 
      "https://app.dimensions.ai/details/publication/pub.1112761617"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78944_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11864-019-0627-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11864-019-0627-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11864-019-0627-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11864-019-0627-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11864-019-0627-4'


 

This table displays all metadata directly associated to this object as RDF triples.

186 TRIPLES      21 PREDICATES      64 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11864-019-0627-4 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N1f8317013cd34aafb942cb0e825b8d05
4 schema:citation sg:pub.10.1007/s00277-015-2364-5
5 sg:pub.10.1038/leu.2013.318
6 sg:pub.10.1038/leu.2014.90
7 sg:pub.10.1038/s41375-018-0326-3
8 sg:pub.10.1038/sj.leu.2404313
9 https://app.dimensions.ai/details/publication/pub.1074581593
10 https://app.dimensions.ai/details/publication/pub.1082552338
11 https://doi.org/10.1016/s1470-2045(18)30580-1
12 https://doi.org/10.1056/nejmoa1507471
13 https://doi.org/10.1056/nejmra1406184
14 https://doi.org/10.1080/17474086.2017.1326811
15 https://doi.org/10.1097/moh.0000000000000482
16 https://doi.org/10.1111/bjh.12792
17 https://doi.org/10.1111/j.1365-2141.2008.07132.x
18 https://doi.org/10.1111/j.1365-2141.2009.07770.x
19 https://doi.org/10.1182/blood-2009-03-213389
20 https://doi.org/10.1182/blood-2009-04-212530
21 https://doi.org/10.1182/blood-2012-11-468348
22 https://doi.org/10.1182/blood-2013-01-480590
23 https://doi.org/10.1182/blood-2014-05-577593
24 https://doi.org/10.1182/blood-2016-08-733196
25 https://doi.org/10.1182/blood-2017-09-801498
26 https://doi.org/10.1182/bloodadvances.2018016378
27 https://doi.org/10.1200/jco.2009.25.1496
28 https://doi.org/10.1200/jco.2011.35.0371
29 https://doi.org/10.1200/jco.2012.45.9628
30 https://doi.org/10.1200/jco.2013.49.1753
31 https://doi.org/10.1200/jco.2014.58.0571
32 https://doi.org/10.1200/jco.2014.58.3518
33 https://doi.org/10.1200/jco.2016.67.1875
34 https://doi.org/10.1200/jco.2017.76.3425
35 https://doi.org/10.3324/haematol.2009.007765
36 https://doi.org/10.3390/cancers10070215
37 https://doi.org/10.4103/0366-6999.246072
38 https://doi.org/10.6004/jnccn.2017.0116
39 schema:datePublished 2019-04
40 schema:datePublishedReg 2019-04-01
41 schema:description OPINION STATEMENT: Treatment of acute myeloid leukemia (AML) remains a high-risk venture for the patient suffering from the disease. There is a real risk of succumbing to the treatment rather than the disease, and even so, cure is much less than certain. Since the establishment of complete remission as a prerequisite for cure in the 1960s, a number of years passed before advanced techniques for detecting minute amounts of disease matured sufficiently for clinical implementation. The two main techniques for detection of measurable residual disease (MRD) remain qPCR and multicolor flow cytometry. When performed in expert laboratories, both these modalities offer treating physicians excellent opportunity to follow the amount of residual disease upon treatment and offer unparalleled prognostication. In some AML and age group subsets, evidence now exist to support the choice of both proceeding to allogeneic transplant and not doing so. In other AML subgroups, MRD has sufficient discriminative power to identify patients likely to benefit from allogeneic transplant and patients likely not to. After treatment or transplantation, follow-up by molecular techniques can, with high certainty, predict relapse months before bone marrow function deterioration. On the other hand, options upon so-called molecular relapse are less well tested but recent evidence supports the use of azacitidine both in transplanted patients and patients consolidated with chemotherapy. In conclusion, MRD testing during treatment is a superb prognosticator and a major tool when choosing whether a patient should be transplanted or not. The exact use of MRD testing after treatment is less well defined but evidence is mounting for the instigation of treatment upon rising MRD levels (pre-emptive treatment) before morphologically detectable relapse.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N62f00d19a1cb437983e2d30be5859b67
46 Ne52fe1cedde0441ea0ce92238a7f2325
47 sg:journal.1022080
48 schema:name Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia
49 schema:pagination 28
50 schema:productId N634fc85679ae40d887fc979b248b860f
51 N6cd68c63e5df4db0909a200a2f94c699
52 Nbe73a2cea51a4f84b9c0941527d76ef6
53 Nd8c8b509ac6849719972faec0c8e8777
54 Ne82e90bfa03145e2acb6f4de300dadc5
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112761617
56 https://doi.org/10.1007/s11864-019-0627-4
57 schema:sdDatePublished 2019-04-11T13:18
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N3940dfbe01644324a94e893044a8cccb
60 schema:url https://link.springer.com/10.1007%2Fs11864-019-0627-4
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N03b84c8fe83645e08f95a94aa13cce17 schema:affiliation https://www.grid.ac/institutes/grid.154185.c
65 schema:familyName Ommen
66 schema:givenName Hans Beier
67 rdf:type schema:Person
68 N1f8317013cd34aafb942cb0e825b8d05 rdf:first N8eed5fd42b3a48f1bfa326b2cf4247f4
69 rdf:rest N528de2b6b9fe40a699dd615cfd1f4ff7
70 N3940dfbe01644324a94e893044a8cccb schema:name Springer Nature - SN SciGraph project
71 rdf:type schema:Organization
72 N528de2b6b9fe40a699dd615cfd1f4ff7 rdf:first N03b84c8fe83645e08f95a94aa13cce17
73 rdf:rest rdf:nil
74 N62f00d19a1cb437983e2d30be5859b67 schema:volumeNumber 20
75 rdf:type schema:PublicationVolume
76 N634fc85679ae40d887fc979b248b860f schema:name pubmed_id
77 schema:value 30874904
78 rdf:type schema:PropertyValue
79 N6cd68c63e5df4db0909a200a2f94c699 schema:name nlm_unique_id
80 schema:value 100900946
81 rdf:type schema:PropertyValue
82 N8eed5fd42b3a48f1bfa326b2cf4247f4 schema:affiliation https://www.grid.ac/institutes/grid.5117.2
83 schema:familyName Roug
84 schema:givenName Anne Stidsholt
85 rdf:type schema:Person
86 Nbe73a2cea51a4f84b9c0941527d76ef6 schema:name dimensions_id
87 schema:value pub.1112761617
88 rdf:type schema:PropertyValue
89 Nd8c8b509ac6849719972faec0c8e8777 schema:name readcube_id
90 schema:value 4ec7c380fc81716e136a5338d69a157bc38c92e0e90a88743a0e9af5b6fea2f4
91 rdf:type schema:PropertyValue
92 Ne52fe1cedde0441ea0ce92238a7f2325 schema:issueNumber 4
93 rdf:type schema:PublicationIssue
94 Ne82e90bfa03145e2acb6f4de300dadc5 schema:name doi
95 schema:value 10.1007/s11864-019-0627-4
96 rdf:type schema:PropertyValue
97 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
98 schema:name Medical and Health Sciences
99 rdf:type schema:DefinedTerm
100 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
101 schema:name Oncology and Carcinogenesis
102 rdf:type schema:DefinedTerm
103 sg:journal.1022080 schema:issn 1527-2729
104 1534-6277
105 schema:name Current Treatment Options in Oncology
106 rdf:type schema:Periodical
107 sg:pub.10.1007/s00277-015-2364-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031095879
108 https://doi.org/10.1007/s00277-015-2364-5
109 rdf:type schema:CreativeWork
110 sg:pub.10.1038/leu.2013.318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039759999
111 https://doi.org/10.1038/leu.2013.318
112 rdf:type schema:CreativeWork
113 sg:pub.10.1038/leu.2014.90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004209539
114 https://doi.org/10.1038/leu.2014.90
115 rdf:type schema:CreativeWork
116 sg:pub.10.1038/s41375-018-0326-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110559543
117 https://doi.org/10.1038/s41375-018-0326-3
118 rdf:type schema:CreativeWork
119 sg:pub.10.1038/sj.leu.2404313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029511634
120 https://doi.org/10.1038/sj.leu.2404313
121 rdf:type schema:CreativeWork
122 https://app.dimensions.ai/details/publication/pub.1074581593 schema:CreativeWork
123 https://app.dimensions.ai/details/publication/pub.1082552338 schema:CreativeWork
124 https://doi.org/10.1016/s1470-2045(18)30580-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109824401
125 rdf:type schema:CreativeWork
126 https://doi.org/10.1056/nejmoa1507471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001798183
127 rdf:type schema:CreativeWork
128 https://doi.org/10.1056/nejmra1406184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011899386
129 rdf:type schema:CreativeWork
130 https://doi.org/10.1080/17474086.2017.1326811 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085346701
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1097/moh.0000000000000482 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111027519
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1111/bjh.12792 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011762816
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1111/j.1365-2141.2008.07132.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038105173
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1111/j.1365-2141.2009.07770.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032893066
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1182/blood-2009-03-213389 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008844336
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1182/blood-2009-04-212530 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010662814
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1182/blood-2012-11-468348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010315401
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1182/blood-2013-01-480590 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052849109
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1182/blood-2014-05-577593 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050367002
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1182/blood-2016-08-733196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064123306
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1182/blood-2017-09-801498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100381779
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1182/bloodadvances.2018016378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104568608
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1200/jco.2009.25.1496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016977002
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1200/jco.2011.35.0371 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038855887
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1200/jco.2012.45.9628 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017813803
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1200/jco.2013.49.1753 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011453119
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1200/jco.2014.58.0571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040750785
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1200/jco.2014.58.3518 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002897148
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1200/jco.2016.67.1875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035196420
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1200/jco.2017.76.3425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101852368
171 rdf:type schema:CreativeWork
172 https://doi.org/10.3324/haematol.2009.007765 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040541320
173 rdf:type schema:CreativeWork
174 https://doi.org/10.3390/cancers10070215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105127918
175 rdf:type schema:CreativeWork
176 https://doi.org/10.4103/0366-6999.246072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110162477
177 rdf:type schema:CreativeWork
178 https://doi.org/10.6004/jnccn.2017.0116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090396386
179 rdf:type schema:CreativeWork
180 https://www.grid.ac/institutes/grid.154185.c schema:alternateName Aarhus University Hospital
181 schema:name Department of Hematology, Aarhus University Hospital, Palle-Juul Jensens Boulevard 99, DK-8200, Aarhus N, Denmark
182 rdf:type schema:Organization
183 https://www.grid.ac/institutes/grid.5117.2 schema:alternateName Aalborg University
184 schema:name Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
185 Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Mølleparkvej 4, DK-9000, Aalborg, Denmark
186 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...